Phase I Dose Escalation Study of VS-5584 in Subjects With Advanced Non-Hematologic Malignancies or Lymphoma
This study is currently recruiting participants.
(see Contacts and Locations)
Verified April 2014 by Verastem, Inc.
Sponsor:
Verastem, Inc.
Information provided by (Responsible Party):
Verastem, Inc.
ClinicalTrials.gov Identifier:
NCT01991938
First received: November 18, 2013
Last updated: April 25, 2014
Last verified: April 2014
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | October 2015 (Final data collection date for primary outcome measure) |